Your account is not claimed yet. You can sign up with ORCID to claim your account.

Li Zheng

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Circulating Tumor

Tyrosine Kinase

Top Venues

The EMBO journal

Science (New York, N.Y.)

Nucleic acids research

City of Hope National Medical Center

Kansas State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

City of Hope National Medical Center Oct 1o 2016

United States

Associate Professor/Research :: Cancer Genetics and Epigenetics

Education History

Kansas State University Aug 26o 1996 - Dec 30o 2000

United States

PHD :: Biochemistry

Publications

Wenpeng Liu, Piotr Polaczek, Ivan Roubal, Yuan Meng, Won-Chae Choe, Marie-Christine Caron, Carl A Sedgeman, Yu Xi, Changwei Liu, Qiong Wu, Li Zheng, Jean-Yves Masson, Binghui Shen, Judith L Campbell
FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability. Nucleic acids research (2023)
Bing Liu, Daniela Duenas, Li Zheng, Karen L Reckamp, Binghui Shen
Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer. Protein & cell (2021)
Haitao Sun, Zhaoning Lu, Amanpreet Singh, Yajing Zhou, Eric Zheng, Mian Zhou, Jinhui Wang, Xiwei Wu, Zunsong Hu, Zhaohui Gu, Judith L Campbell, Li Zheng, Binghui Shen
Error-prone, stress-induced 3' flap-based Okazaki fragment maturation supports cell survival. Science (New York, N.Y.) 374 (6572) (2021)
Zhengke Li, Bochao Liu, Weiwei Jin, Xiwei Wu, Mian Zhou, Vincent Zewen Liu, Ajay Goel, Zhiyuan Shen, Li Zheng, Binghui Shen
hDNA2 nuclease/helicase promotes centromeric DNA replication and genome stability. The EMBO journal 37 (14) (2018)